Infectious Disease Diagnostic Market to Rise at CAGR of 7.1% to Reach USD 2,987.7 Million by 2034

Trend Toward Customized Diagnostic Solutions Boosts Growth in the Infectious Disease Diagnostic Market. Fact.MR Reports

The global infectious disease diagnostic market size is valued at US$ 1.503.8 million in 2024 and is projected to expand at a 7.1% CAGR through 2034. The market is estimated to cross a valuation of US$ 2,987.7 million by 2034.

The move toward personalized diagnostics is a response to the demand for targeted approaches in the treatment of infectious diseases. Forward-thinking businesses create specialized instruments for particular infections or specific illness patterns. This calls for a thorough comprehension of the special difficulties presented by various contagious illnesses and the capacity to create and produce diagnostics that successfully meet these difficulties. Businesses set themselves apart in the market by providing specialist solutions, which draw in researchers and healthcare professionals looking for accurate and customized diagnostic instruments.

A profitable market niche emerges for infectious disease diagnostic firms due to the growing global elderly population. Due to their increased vulnerability to various infectious illnesses, older people require advanced diagnostic equipment designed to meet their healthcare demands. Companies that properly position themselves to serve this demographic transition by addressing the unique diagnostic needs of aging populations can gain a considerable market share and achieve sustained success.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9586

Key Takeaways from the Market Report:

• The infectious disease diagnostic market stood at US$ 1,054.4 million in 2019.
• The North America infectious disease diagnostic industry is estimated to hold 20.9% of shares in 2024.
• The market for infectious disease diagnostics in East Asia is anticipated to hold 17.7% of the shares in 2024.
• The STDs disease indication segment occupied 35.4% of the market shares in 2024.
• The cell culture technique segment captured a 39.1% share of the market in 2024.
• The market size in the United States is projected to rise at a 6.7% CAGR through 2034.
• The market size in China is anticipated to develop at an 8.7% CAGR through 2034.

"Strategic creativity, collaboration, and technology adoption are required to succeed in the infectious disease diagnostic market. Leading organizations investing in innovation and sustainability are likely to thrive in this volatile environment, preparing themselves for long-term success.”Says a Fact.MR analyst.

Leading Players Driving Innovation in the Infectious Disease Diagnostic Market:

Roche Diagnostics; Abbott Laboratories; Siemens Healthineers; Thermo Fisher Scientific; BioMérieux SA; Becton, Dickinson and Company; Cepheid (a Danaher Corporation company); Hologic, Inc.; QIAGEN N.V.; Bio-Rad Laboratories, Inc.; Luminex Corporation; Ortho Clinical Diagnostics; DiaSorin S.p.A.; Meridian Bioscience, Inc.; GenMark Diagnostics, Inc.

Competitive Landscape:

The infectious disease diagnostic industry is extremely competitive, with key competitors such as Abbott, Roche, and Siemens driving the market. Businesses prioritize innovation, regulatory compliance, and worldwide expansion. The ability to introduce cutting-edge technology, navigate regulatory constraints, and personalize solutions to varied markets is critical to success. Effective consumer engagement and adaption to value-based care models are essential for market supremacy. The dynamics of the market center primarily around innovation, regulatory prowess, and strategic global presence.

Recent Developments:

• In November 2023, Apollo Cancer Centres (ACCs) introduced the Breast Cancer Diagnosis Program, which is India's fastest & precise program. The project aims to provide quick and accurate breast cancer diagnostics, highlighting the importance of early detection in identifying the best treatment for patients and enhancing their quality of life.
• In October 2023, Precede Biosciences hit the market with cell-free genomic diagnostics for drug development and precision medicine.

Infectious Disease Diagnostic Market News:

1. In November 2023, Apollo Cancer Centres (ACCs) introduced 'India's Fastest & Accurate Breast Cancer Diagnosis Program.' The initiative aims to provide fast and accurate breast cancer diagnosis, highlighting the need for early detection in deciding on the most suitable therapy for the patients and enhancing their quality of life.
2. In October of 2023, Precede Biosciences launched on the market with cell-free genomic diagnostics for drug discovery and precision medicine.

Get Customization on this Report for Specific Research Solutions:https://www.factmr.com/connectus/sample?flag=S&rep_id=9586

More Valuable Insights on Offer:

Fact.MR, in its new offering, presents an unbiased analysis of the global infectious disease diagnostic market, presenting historical data for 2020 to 2024 and forecast statistics for 2025 to 2035.

The study reveals essential insights on the basis of the disease indication, technique, end user, and region. By disease indication, it includes CNS infections, diarrheal diseases, respiratory infections, blood infections, and STDs. Diagnostic techniques comprise ELISA, polymerase chain reaction (PCR), immunoassays, cell cultures, and others. End users in the market include hospitals, diagnostic centers, clinics, and government organizations. Geographically, the market is analyzed across North America, Europe, Latin America, East Asia, South Asia & Oceania, and the Middle East & Africa.

Check out More Related Studies Published by Fact.MR Research:

The global bipolar disorder therapeutics market will account for US$ 5.9 Bn in 2022, and is anticipated to reach a valuation of US$ 6.8 Bn by the end of 2026.

The global organ preservation solutions market currently accounts for a valuation of US$ 233 million and is anticipated to reach US$ 330 million by the end of 2027. Worldwide demand for organ preservation solutions is forecasted to accelerate at a CAGR of 7.2% from 2022 to 2027.

The Europe cesspit emptier market is set to enjoy a valuation of US$ 338 Million in 2023 and further expand at a CAGR of 4.3% to reach US$ 515 Million by the end of 2033.

According to Fact.MR, the global dental membrane and bone graft substitutes market was valued at around US$ 500 Mn in 2020, and is projected to expand 1.8X to top US$ 900 Mn by 2031.

Worldwide sales of ECG telemetry devices are valued at US$ 2.65 billion in 2023. The global electrocardiography (ECG) telemetry devices market is forecasted to expand rapidly at a CAGR of 8% and reach a market valuation of US$ 5.72 billion by 2033.